Authors
Loading...
This immunosensing platform improves antibody attachment using a hydrophobin-protein A fusion on gold nanoparticles, suggesting enhanced diagnostic capabilities.
Cicatiello et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: